India's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Most investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...

For India to leverage its Free Trade Agreements effectively, a paradigm shift in strategy is imperative. Experts caution that the disparity...

Venus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...

The Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

Between 2024 and early 2026, India’s real estate landscape witnessed an astonishing influx of over $30 billion in equity capital, showcasin...

Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...

The country's healthcare and pharmaceutical sector is moving into a capability-led growth phase, with hiring increasingly focused on specia...

A high dividend yield by itself is not a sign of safety. Sometimes, a stock yields more only because the price has collapsed for a valid re...

Quant Mutual Fund believes the current market situation presents a major buying chance. The fund house is increasing its investments in sto...

Alternative data and benchmarking are helping lenders assess companies with limited disclosures, says Mohan Ramaswamy, Founder and CEO, Rub...

Novo Nordisk is slashing prices for its diabetes and weight loss drugs Ozempic and Wegovy in India. This move aims to make these treatments...

New bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...

Indian pharmaceutical company, Sun Pharma, inaugurated a new plant in Bangladesh, strengthening economic ties and promoting collaboration i...

Generic drugs form the largest segment, with 75 per cent of market share (in terms of revenues), of the Indian pharmaceutical sector.